Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 7:50 pm Purchase | 2025-10-23 | 13D | Rani Therapeutics Holdings, Inc. RANI | Samsara BioCapital, L.P. | 9,882,477 9.900% | 9,882,477 (New Position) | Filing History |
| 2025-10-21 4:07 pm Purchase | 2025-05-07 | 13D | Inventiva S.A. IVA | Samsara BioCapital, L.P. | 8,161,942 5.900% | 8,161,942 (New Position) | Filing History |
| 2025-10-07 9:00 pm Purchase | 2025-10-03 | 13D | Scholar Rock Holding Corporation SRRK | Samsara BioCapital, L.P. | 6,991,553 7.200% | 234,298 (+3.47%) | Filing History |
| 2025-09-25 5:06 pm Unchanged | 2025-09-22 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 343,223 9.900% | 0 (Unchanged) | Filing History |
| 2025-09-08 8:05 pm Purchase | 2025-09-04 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 6,346,194 8.200% | 609,889 (+10.63%) | Filing History |
| 2025-09-03 7:33 pm Purchase | 2025-08-29 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 343,223 9.900% | 77,603 (+29.22%) | Filing History |
| 2025-08-14 5:28 pm Unchanged | 2025-06-30 | 13G | Leap Therapeutics, Inc. LPTX | Samsara BioCapital, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:28 pm Sale | 2025-06-30 | 13G | OnKure Therapeutics, Inc. OKUR | Samsara BioCapital, L.P. | 0 0.000% | -824,155 (Position Closed) | Filing History |
| 2025-08-14 5:26 pm Sale | 2025-06-30 | 13G | Palvella Therapeutics, Inc. PVLA | Samsara BioCapital, L.P. | 339,743 3.100% | -339,743 (-50.00%) | Filing History |
| 2025-05-23 8:49 pm Purchase | 2025-05-21 | 13D | Alumis Inc. Common Stock ALMS | Samsara BioCapital, L.P. | 4,801,370 5.000% | 4,801,370 (New Position) | Filing History |
| 2025-03-27 6:17 pm Sale | 2024-11-18 | 13D | Syros Pharmaceuticals, Inc. SYRS | Samsara BioCapital, L.P. | 707,114 2.600% | -1,808,409 (-71.89%) | Filing History |
| 2025-03-25 7:40 pm Purchase | 2025-03-18 | 13D | Kalaris Therapeutics Inc KLRS | Samsara BioCapital, L.P. | 11,448,081 61.200% | 11,448,081 (New Position) | Filing History |
| 2025-03-17 9:06 pm Purchase | 2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS | Samsara BioCapital, L.P. | 5,736,305 9.100% | 644,278 (+12.65%) | Filing History |
| 2025-02-14 5:54 pm Sale | 2024-12-31 | 13G | IO Biotech, Inc. IOBT | Samsara BioCapital, L.P. | 2,631,578 3.800% | -1,008,437 (-27.70%) | Filing History |
| 2024-12-20 4:59 pm Purchase | 2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA | Samsara BioCapital, L.P. | 679,486 6.100% | 679,486 (New Position) | Filing History |
| 2024-11-27 4:25 pm Purchase | 2024-11-25 | 13G | Neurogene Inc. NGNE | Samsara BioCapital, L.P. | 1,717,127 11.600% | 434,564 (+33.88%) | Filing History |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA | Samsara BioCapital, L.P. | 65,635 4.980% | 10,030 (+18.04%) | Filing History |
| 2024-11-14 5:45 pm Purchase | 2024-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX | Samsara BioCapital, L.P. | 4,415,689 9.600% | 294,000 (+7.13%) | Filing History |
| 2024-11-04 4:15 pm Purchase | 2024-10-28 | 13G | Septerna, Inc. SEPN | Samsara BioCapital, L.P. | 2,768,520 6.200% | 2,768,520 (New Position) | Filing History |
| 2024-10-11 4:15 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Samsara BioCapital, L.P. | 824,155 6.500% | 824,155 (New Position) | Filing History |